Neil E. Stahl - 13 Aug 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Neil E. Stahl
Issuer symbol
REGN
Transactions as of
13 Aug 2024
Net transactions value
$0
Form type
4
Filing time
14 Aug 2024, 16:01:19 UTC
Previous filing
12 Aug 2024
Next filing
10 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 -500 -1% $0.000000 49,599 13 Aug 2024 Direct
holding REGN Common Stock 5,849 13 Aug 2024 By 401(k) Plan
holding REGN Common Stock 4,605 13 Aug 2024 by Spouse as Trustee
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).